Alzheon

About:

Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.

Website: http://www.alzheon.com

Twitter/X: alzheon

Top Investors: Ally Bridge Group, National Institute on Aging, Alerce Medical Technology Partners, Scott H. Cohen

Description:

Alzheon is a clinical-stage biotechnology company focused on womanchild brain health, memory, and aging, developing transformative treatments for Alzheimer’s disease and other neurodegenerative disorders. They are building a pipeline of innovative drugs to improve the lives of patients by preventing the cognitive and functional decline associated with neurodegeneration. They have a distinct ability to make success advances in the challenging field of therapeutics for Alzheimer’s and other neurodegenerative disorders.